BioAffinity Technologies, Inc. (NASDAQ:BIAF) shares are moving higher on Tuesday after the company reported 2024 fiscal-year earnings, showing multiple year-over-year increases. What To Know: The ...

BioAffinity Technologies, Inc. (NASDAQ:BIAF) shares are trading lower by 50.7% to $1.48 during Wednesday’s session after the company announced a securities purchase agreement with institutional ...

SAN ANTONIO - bioAffinity Technologies, Inc. (NASDAQ:BIAF; BIAFW), a company specializing in noninvasive early-stage lung cancer diagnostics, announced today the acceptance of its patent application ...

SAN ANTONIO, March 06, 2025--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage ...

bioAffinity Technologies also announced that Gary Rubin stepped down from the Board of Directors for personal reasons and not due to any disagreement with the Company or its operations, policies or ...

bioAffinity Technologies, Inc. ( (BIAF)) just unveiled an announcement. On November 5, 2025, bioAffinity Technologies announced significant growth in the volume of their CyPath® Lung tests, with ...

SAN ANTONIO--(BUSINESS WIRE)--Here is a summary of the latest news about bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the ...

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...

Welcome back to Earnings Roundup, SA Inc's weekly summary of the latest quarterly financial reports from companies of local interest. Look for it online every Monday during quarterly and annual ...